Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.
Launched by YUSRA MEDICAL AND DENTAL COLLEGE · Oct 4, 2023
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cerebrovascular accident(CVA) or stroke is one of common condition affecting people in developed and underdeveloped countries. Mostly patient with stroke face many disabilities and the most important one is upper limb motor impairment. For the optimization of upper extremity and prevention of patient from permanent disability it is essential to promotes Neuro-rehabilitation interventions. Physiotherapy techniques need to be monotonous, thorough and task oriented for neuroplasticity to generate better recovery. There is notable enhancement in ADLS when the rehabilitation program starts withi...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Acute(hemiplegic attack within 1-2 weeks) and sub-acute stroke(hemiplegic attack within 3- 11 weeks).
- • 20 to 80 years.
- • No physical deformity prior to stroke
- • No history of serious underlying pathology and structural deformities.
- Exclusion Criteria:
- • Patient with chronic hemiplegic stroke.
- • Patient with congenital deformity.
About Yusra Medical And Dental College
Yusra Medical and Dental College is a distinguished educational institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering medical and dental excellence, the college integrates cutting-edge scientific inquiry with comprehensive training programs, aiming to enhance patient care and medical knowledge. With a focus on ethical practices and community health, Yusra Medical and Dental College actively engages in clinical trials that contribute to the development of effective therapies and treatments, positioning itself as a leader in the medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported